Congo starts re-deployment of expiring COVID-19 vaccines to other African countries

A nurse holds up a vial of the AstraZeneca coronavirus disease (COVID-19) vaccine at the Ngaliema Clinic in Kinshasa
A nurse holds up a vial of the AstraZeneca coronavirus disease (COVID-19) vaccine at the Ngaliema Clinic in Kinshasa, Democratic Republic of Congo, April 29, 2021. REUTERS/Hereward Holland

KINSHASA, April 29 (Reuters) - The Democratic Republic of Congo has begun re-deploying hundreds of thousands of COVID-19 vaccines to other African nations which it says it won't be able to administer before they expire at the end of June, its health minister said on Thursday.

On Thursday afternoon a plane from Angola picked up almost half a million doses of the AstraZeneca (AZN.L) vaccine, which had been supplied to Congo through the COVAX vaccine-sharing facility on March 2.

Congo delayed its rollout after several European countries suspended use of the AstraZeneca shot in response to reports of rare blood clots. read more

Ghana, Togo, Central African Republic and Madagascar will also receive some of the 1.3 million doses Congo is reallocating, health minister Jean-Jacques Mbungani told Reuters.

"It is a sign of solidarity that the Congo is giving to its brother countries," Mbungani said.

Congo will recover those doses via the COVAX scheme at a later date, he said. "It's important to redeploy, that's the right term, it's not a donation."

Congo received 1.7 million doses, but has vaccinated just 2,035 people in the nine days since it started the rollout, the minister said. read more

The country has recorded just 30,000 coronavirus cases, resulting in 763 deaths.

COVAX, which is backed by the World Health Organization, aims to deliver 600 million shots - most of them from AstraZeneca - to some 40 African countries this year. That would be enough to vaccinate 20% of their populations.

The situation in Congo illustrates the challenges many African countries face rolling out such large-scale vaccination campaigns despite their experience battling deadly infectious diseases.

Some health authorities do not have sufficient personnel and training to distribute vaccines at short notice and lack vital equipment because of funding shortfalls that could total billions of dollars, according to experts. read more

Reporting by Hereward Holland and Jessica Agasaro; writing by Hereward Holland Editing by Raissa Kasolowsky

Our Standards: The Thomson Reuters Trust Principles.